Cubist Systematic Strategies’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3.43M Buy
18,500
+10,400
+128% +$1.78M 0.02% 1224
2025
Q2
$1.24M Sell
8,100
-7,000
-46% -$1.08M 0.01% 1832
2025
Q1
$2.5M Sell
15,100
-16,300
-52% -$2.55M 0.02% 1292
2024
Q4
$4.54M Buy
31,400
+8,000
+34% +$1.24M 0.03% 897
2024
Q3
$3.79M Sell
23,400
-7,600
-25% -$1.21M 0.02% 1005
2024
Q2
$4.53M Buy
31,000
+8,500
+38% +$1.26M 0.03% 838
2024
Q1
$3.56M Sell
22,500
-2,700
-11% -$430K 0.02% 1206
2023
Q4
$3.95M Sell
25,200
-72,900
-74% -$11.2M 0.03% 1017
2023
Q3
$15.3M Buy
98,100
+18,900
+24% +$3.12M 0.11% 194
2023
Q2
$13.1M Buy
79,200
+10,600
+15% +$1.71M 0.09% 296
2023
Q1
$10.6M Buy
68,600
+32,000
+87% +$5.17M 0.06% 426
2022
Q4
$6.47M Buy
36,600
+3,400
+10% +$587K 0.04% 806
2022
Q3
$5.42M Buy
33,200
+20,000
+152% +$3.38M 0.03% 1007
2022
Q2
$2.34M Buy
+13,200
New +$2.35M 0.01% 1698

Other funds holding JNJ

Cubist Systematic Strategies's JNJ Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 202,059 shares — an estimated $34.6M sold.

Cubist Systematic Strategies first reported a position in JNJ in Q2 2014 and held it in 42 quarters. The position peaked at $33.3M in Q1 2024. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 202,059 Johnson & Johnson shares in Q3 2025, an estimated $34.6M.
  • Cubist Systematic Strategies first reported a position in Johnson & Johnson in Q2 2014 and held it in 42 quarters.
  • Cubist Systematic Strategies's Johnson & Johnson position peaked at $33.3M in Q1 2024.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.